Lilly dropping Hanmi's BTK inhibitor
Eli Lilly and Co. (NYSE:LLY) discontinued from its pipeline a Bruton's tyrosine kinase (Btk) inhibitor it had licensed from Hanmi Pharmaceutical Co. Ltd. (KSE:128940). The pharma...
Eli Lilly and Co. (NYSE:LLY) discontinued from its pipeline a Bruton's tyrosine kinase (Btk) inhibitor it had licensed from Hanmi Pharmaceutical Co. Ltd. (KSE:128940). The pharma...